CELL BIOLOGY AND METABOLISM
Role of Isoprenoid Lipids on the Heterotrimeric G Protein γ Subunit in Determining Effector Activation*

https://doi.org/10.1074/jbc.274.23.16595Get rights and content
Under a Creative Commons license
open access

Post-translational prenylation of heterotrimeric G protein γ subunits is essential for high affinity α-βγ and α-βγ-receptor interactions, suggesting that the prenyl group is an important domain in the βγ dimer. To determine the role of the prenyl modification in the interaction of βγ dimers with effectors, the CAAX (where A indicates alipathic amino acid) motifs in the γ1, γ2, and γ11 subunits were altered to direct modification with different prenyl groups. Six recombinant βγ dimers were overexpressed in baculovirus-infected Sf9 insect cells, purified, and examined for their ability to stimulate three phospholipase C-β isozymes and type II adenylyl cyclase. The native β1γ2 dimer (γ subunit modified with geranylgeranyl) is more potent and effective in activating phospholipase C-β than either the β1γ1 (farnesyl) or the β1γ11 (farnesyl) dimers. However, farnesyl modification of the γ subunit in the β1γ2dimer (β1γ2-L71S) caused a decrement in its ability to activate phospholipase C-β. In contrast, both the β1γ1-S74L (geranylgeranyl) and the β1γ11-S73L (geranylgeranyl) dimers were more active than the native forms. The β1γ2dimer activates type II adenylyl cyclase about 12-fold; however, neither the β1γ1 nor the β1γ11 dimers activate the enzyme. As was the case with phospholipase C-β, the β1γ2-L71S dimer was less able to activate adenylyl cyclase than the native β1γ2dimer. Interestingly, neither the β1γ1-S74Lnor the β1γ11-S73L dimers stimulated adenylyl cyclase. The results suggest that both the amino acid sequence of the γ subunit and its prenyl group play a role in determining the activity of the βγ-effector complex.

Cited by (0)

*

This work was supported by the National Institutes of Health Grants PO1-CA-40042 and RO1-DK-19952 and by United States Public Health Service Grant GM-29536.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§

Present address: Dept. of Medicine, University of Tokyo, Tokyo 112-8688, Japan.

Present address: IDEXX Laboratories, Inc., One IDEXX Drive, Westbrook, ME 04092.